The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction

Por Sharma, Arpeeta, Rizky, Luddwi, Stefanovic, Nada, Tate, Mitchel, Ritchie, Rebecca H., Ward, Keith W., de Haan, Judy B.
Publicado no Cardiovasc Diabetol (2017)

The Modified Selenenyl Amide, M-hydroxy Ebselen, Attenuates Diabetic Nephropathy and Diabetes-Associated Atherosclerosis in ApoE/GPx1 Double Knockout Mice

Por Tan, Sih Min, Sharma, Arpeeta, Yuen, Derek Y. C., Stefanovic, Nada, Krippner, Guy, Mugesh, Govindasamy, Chai, Zhonglin, de Haan, Judy B.
Publicado em 2013

Antiatherosclerotic and Renoprotective Effects of Ebselen in the Diabetic Apolipoprotein E/GPx1-Double Knockout Mouse

Por Chew, Phyllis, Yuen, Derek Y.C., Stefanovic, Nada, Pete, Josefa, Coughlan, Melinda T., Jandeleit-Dahm, Karin A., Thomas, Merlin C., Rosenfeldt, Franklin, Cooper, Mark E., de Haan, Judy B.
Publicado em 2010